AIC
ABMD

Ameritas Investment Company’s Abiomed Inc ABMD Stock Holding History

Ameritas Investment Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89
Closed -$28.4K – 2218
2021
Q1 		$28.4K Buy
+89
New +$28.5K ﹤0.01% 1149
2019
Q1 		– Sell
-525
Closed -$171K – 1893
2018
Q4 		$171K Buy
+525
New +$182K 0.04% 318

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Ameritas Investment Company's ABMD Position: Q2 2021 in Review

Ameritas Investment Company sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 89 shares — an estimated $28.4K sold.

Ameritas Investment Company first reported a position in ABMD in Q4 2018 and held it in 2 quarters. The position peaked at $171K in Q4 2018. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Ameritas Investment Company reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 89 Abiomed Inc shares in Q2 2021, an estimated $28.4K.
  • Ameritas Investment Company first reported a position in Abiomed Inc in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Abiomed Inc position peaked at $171K in Q4 2018.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.